Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO)

Author:

Leonardi Luca1ORCID,Costanzo Rocco1,Forcina Francesca1,Morino Stefania1,Antonini Giovanni1,Salvetti Marco12,Luigetti Marco34ORCID,Romano Angela3,Primiano Guido3,Guglielmino Valeria4,Fionda Laura1ORCID,Garibaldi Matteo1,Lauletta Antonio1,Rossini Elena1,Tufano Laura1,Ceccanti Marco5,Esposito Nicoletta5,Falco Pietro5,di Pietro Giuseppe5ORCID,Truini Andrea5ORCID,Galosi Eleonora5ORCID

Affiliation:

1. Department of Neuroscience, Mental Health and Sensory Organs (NESMOS) Sapienza University of Rome Rome Italy

2. Neuromed Institute IRCCS Pozzilli Isernia Italy

3. UOC Neurologia Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy

4. Dipartimento di Neuroscienze Università Cattolica del Sacro Cuore. Sede di Roma Rome Italy

5. Department of Human Neuroscience Sapienza University of Rome Rome Italy

Abstract

AbstractIntroductionHereditary transthyretin amyloidosis polyneuropathy (ATTRv‐PN) presymptomatic carriers often show preclinical abnormalities at small fiber‐related diagnostic tests. However, no validated biomarker is currently available to use for presymptomatic carriers' follow‐up, thus helping therapeutic decision making. Our study aimed at assessing nerve conduction study (NCS), quantitative sensory testing (QST), and skin biopsy parameters in a large cohort of late‐onset ATTRv presymptomatic carriers and to evaluate whether they correlated with predicted age of disease onset (PADO).MethodsLate‐onset ATTRv presymptomatic carriers were consecutively enrolled and underwent NCS, QST, and skin biopsy with intraepidermal nerve fiber density (IENFD) evaluation from a distal and a proximal site. Douleur Neuropathique‐4 (DN4) and Small Fiber Neuropathy‐Symptoms Inventory (SFN‐SIQ) were used to assess painful and small fiber neuropathy‐related symptoms. PADO and time‐to‐PADO (delta‐PADO) were estimated for each carrier, and correlations with diagnostic test measures were analyzed.ResultsForty presymptomatic ATTRv subjects were enrolled. Twenty carriers (50%) had distal IENFD reduction, with a non‐length‐dependent distribution in 73% of cases. Eleven subjects (27.5%) had cold and/or warm detection threshold (CDT and/or WDT) abnormalities at QST. Delta‐PADO positively correlated with sural sensory nerve action potential (SNAP) amplitude (r = .416, p = .004), and z‐values of QST parameters like CDT (r = .314, p = .028), WDT (r = −.294, p = .034), and mechanical detection threshold (MDT; r = −.382, p = .012). Simple linear regression models showed a linear relation between delta‐PADO and sural SAP, CDT, and MDT.ConclusionsOur findings confirm that IENFD reduction and QST abnormalities may occur early in ATTRv presymptomatic carriers, often with a non‐length‐dependent pattern. However, only sural SAP amplitude and QST parameters correlated with delta‐PADO, suggesting that serial combined QST and NCS evaluation could be useful in ATTRv presymptomatic carriers' follow‐up.

Funder

Alnylam Pharmaceuticals

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3